MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/oncolo/oyag119

Медицинская библиотека · The oncologist · 2026

MyCODE: a prospective evaluation of lay-language molecular tumor board protocols in precision oncology.

Pretzell Ina, Fleischhauer Anke, Mavroeidi Ilektra, Prasuhn Nicola, Kaminski Katharina, Bender Noëlle, Grünwald Viktor, Holly Jessica, Hörbelt-Grünheidt Tina, Pakull Tabea, Rosery Vivian, Schürmann Hendrik, Bauer Sebastian, Siveke Jens T, Wiesweg Marcel, Zimmer Lisa, Schadendorf Dirk, Schuler Martin, Benson Sven

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Molecular Tumor Boards (MTBs) are a pillar of precision oncology, integrating results of extended molecular profiling into clinical care. Yet, their protocols are typically incomprehensible for patients. Systematic patient-facing communication has remained limited.

METHODS

In the single-center study MyCODE, individually tailored lay-language MTB protocols were developed based on didactic and psychological principles and prospectively evaluated. Using questionnaires adapted and developed for this task, patients with cancer evaluated their individual protocols and overall experience. Treating physicians were surveyed separately.

RESULTS

Forty-three patients were enrolled, 33 (77%; 55% women; median age 65; patients with 10 different cancer entities) returned completed questionnaires. Of those, 82% shared the questionnaire with at least one additional person. Lay-language protocols were perceived as helpful (68% "very," 29% "rather"), well-structured (71% "very," 29% "rather"), and easily comprehensible (63% "very," 31% "rather") by most patients. 85% reported that the protocol improved their understanding of treatment decisions, and 94% perceived them as supportive even if the MTB failed to provide options for precision therapy. Additionally, 13 treating physicians received questionnaires, of which 9 were returned. Responding physicians rated the benefit for patients as high (44%) or very high (44%) and supportive (67%) or rather supportive (33%) for their personal work.

CONCLUSIONS

Providing patients with lay-language MTB protocols is feasible, accepted, and valued even in the absence of therapeutic options. The MyCODE approach seems to enable patient empowerment and to support patients and physicians in shared decision-making in precision oncology.

Для цитирования: Pretzell Ina, Fleischhauer Anke, Mavroeidi Ilektra, Prasuhn Nicola, Kaminski Katharina, Bender Noëlle, Grünwald Viktor, Holly Jessica, Hörbelt-Grünheidt Tina, Pakull Tabea, Rosery Vivian, Schürmann Hendrik, Bauer Sebastian, Siveke Jens T, Wiesweg Marcel, Zimmer Lisa, Schadendorf Dirk, Schuler Martin, Benson Sven. MyCODE: a prospective evaluation of lay-language molecular tumor board protocols in precision oncology.. The oncologist. 2026. DOI: 10.1093/oncolo/oyag119.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.